BOSTON (Reuters) - Citadel, the Chicago-based hedge fund giant led by billionaire Ken Griffin, has so far weathered the coronavirus market storm well, turning a slight profit ...
Keep Reading →
March 24 - Hedge Funds, Insider Trading - Comments
"U.S. equities traded higher on Friday as concerns about Donald Trump's presidency recede for the time being.
Keep Reading →
May 19 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
No major moves in the US stock market this Wednesday morning, as investors digest retail earnings reports and are keeping an eye on oil prices.
Keep Reading →
August 10 - Earnings Report, News - Comments
The markets can’t seem to catch a break in 2016; on Wednesday, all major U.S stock indexes continued to decline.
Keep Reading →
January 13 - Market Movers, News - Comments
Sientra Inc (NASDAQ:SIEN), Select Medical Holdings Corporation (NYSE:SEM), Halozyme Therapeutics, Inc. (NASDAQ:HALO), and Micron Technology, Inc.
Keep Reading →
January 11 - Market Movers, News - Comments
David Cohen and Harold Levy of Iridian Asset Management have significantly increased their stake in Halozyme Therapeutics, Inc.
Keep Reading →
June 9 - Hedge Funds, News - Comments
As a new filing with the Securities and Exchange Commission shows, Daniel Gold's QVT Financial has initiated a passive stake in Aehr Test Systems (NASDAQ:AEHR).
Keep Reading →
April 23 - Hedge Funds, News - Comments
Daniel Gold, the manager of QVT Financial, is bullish on CytRx Corporation (NASDAQ:CYTR).
Keep Reading →
March 24 - Hedge Funds, News - Comments
According to a new filing with the Securities and Exchange Commission, Daniel Gold’s fund, QVT Financial, boosted its stake in China Zenix Auto International Ltd (NYSE:ZX), ...
Keep Reading →
March 12 - Hedge Funds, News - Comments
In the world of small biotech companies, investors are always fishing for the next small fish to be gobbled up by a bigger one since the industry is well-known for its hefty acquisition...
Keep Reading →
September 16 - News - Comments
In the financial world, there are a multitude of gauges shareholders can use to analyze Mr. Market. Two of the most innovative are hedge fund and insider trading interest.
Keep Reading →
September 6 - News - Comments
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Keep Reading →
September 5 - News - Comments
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
Keep Reading →
September 4 - News - Comments
With August winding down, summer won't be around much longer. Several health-care stocks still had hot days this past week, though.
Keep Reading →
September 1 - News - Comments
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7.38% gain YTD as of Aug 2, ...
Keep Reading →
August 10 - News - Comments
One decision led to a double whammy this week for biotech companies Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Viropharma Inc (NASDAQ:VPHM).
Keep Reading →
August 5 - News - Comments
Halozyme Therapeutics, Inc. (NASDAQ:HALO) moved higher by 25% on Friday behind the news of a positive opinion by the European Medicines Agency's Committee for Medicinal Products...
Keep Reading →
July 29 - News - Comments
Xiaflex from Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) is used to treat Dupuytren’s contracture.
Keep Reading →
July 22 - News - Comments
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short.
Keep Reading →
July 2 - News - Comments
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year.
Keep Reading →
June 21 - News - Comments
To most market participants, hedge funds are viewed as underperforming, outdated financial vehicles of the past.
Keep Reading →
June 7 - News - Comments
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment.
Keep Reading →
May 28 - News - Comments
Up, up, and away. That's the motto for the market as a whole so far this year, but it's also especially applicable for a select group of stocks.
Keep Reading →
May 20 - News - Comments
The Motley Fool's annual April Fools' Day joke this year focused on the "hugest bubble in history" that is set to explode.
Keep Reading →
April 6 - News - Comments
The Dow Jones Industrial Average rose by 90 points on Friday -- the exact amount it fell the day before -- on hopes that a deal between the European Union and Cyprus would get...
Keep Reading →
March 25 - News - Comments
It's hard to believe, but the first month of 2013 has already flown by. We ended January the same way we started it: with plenty of health-care stocks crashing.
Keep Reading →
February 2 - News - Comments
Trusts related to Board of Directors member Thomas Tisch purchased about 21,000 shares of Synageva Biopharma Corp (NASDAQ:GEVA) on January 9th at an average price of $47.53 per...
Keep Reading →
January 16 - Insider Trading - Comments
Intel Corporation (NASDAQ:INTC) – Shares in the chip maker are in negative territory this morning, trading lower with the broader market on signs budget talks are stalling ...
Keep Reading →
December 21 - News - Comments
